Revolutionizing Lab Proteins for Food and Medicine: How Prolific Machines’ $55M Series B is Illuminating a New Path to Growth
Two years ago, Prolific Machines unveiled its technology for a unique manufacturing approach to grow cells for industries, including cultivated meat.
In addition, cell growth is hard to optimize because it’s not in a format that machines can understand.
“For the last few decades, the way that we’ve been controlling cells is with molecules,” Kent said.
We add these molecules into the bioreactors and hope for the best.”Prolific Machines’ protein manufacturing bioreactor (Image credit: Prolific Machines) Image Credits: Prolific Machines /Prolific Machines believes it has a way of transitioning away from these molecules to something better: light.
It includes convertible notes and brings Prolific Machines’ total funding to date to $86.5 million.
